Roger Zhang
Director/Board Member at Respira Therapeutics, Inc.
Profile
Roger Zhang is currently a Board Observer at Respira Therapeutics, Inc. and an Associate at Samsara Biocapital LLC.
He previously served as a Board Observer at Mineralys Therapeutics, Inc. and Cargo Therapeutics, Inc. Mr. Zhang holds a graduate degree from Stanford University and an undergraduate degree from the University of British Columbia.
Roger Zhang active positions
Companies | Position | Start |
---|---|---|
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Private Equity Investor | 2020-03-31 |
Respira Therapeutics, Inc.
Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Respira Therapeutics, Inc. engages in provision of pulmonary delivery of therapeutics for respiratory diseases. Its technology Dry Powder Inhaler (DPI), deliver dry powder drug products to the lung more effectively than other DPI technologies. The company was founded in 2010 and is headquartered in Albuquerque, NM. | Director/Board Member | 2021-08-31 |
Former positions of Roger Zhang
Companies | Position | End |
---|---|---|
CARGO THERAPEUTICS, INC. | Director/Board Member | - |
MINERALYS THERAPEUTICS, INC. | Director/Board Member | - |
Training of Roger Zhang
University of British Columbia | Undergraduate Degree |
Stanford University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
MINERALYS THERAPEUTICS, INC. | Health Technology |
CARGO THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Finance |
Respira Therapeutics, Inc.
Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Respira Therapeutics, Inc. engages in provision of pulmonary delivery of therapeutics for respiratory diseases. Its technology Dry Powder Inhaler (DPI), deliver dry powder drug products to the lung more effectively than other DPI technologies. The company was founded in 2010 and is headquartered in Albuquerque, NM. | Health Technology |
- Stock Market
- Insiders
- Roger Zhang